Skip to main content
Donald Small, MD, Oncology, Baltimore, MD, Johns Hopkins Hospital

DonaldSmallMD

Oncology Baltimore, MD

Professor of Oncology, Professor of Pediatrics, Johns Hopkins University School of Medicine; Director, Division of Pediatric Oncology, Kyle Haydock Professor of Oncology

Dr. Small is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Small's full profile

Already have an account?

  • Office

    1800 Orleans St.
    The Charlotte R. Bloomberg Children's Center Building, 11th Floor
    Baltimore, MD 21287
    Phone+1 410-955-8751
    Fax+1 410-955-8897
  • Is this information wrong?

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Pediatric Hematology/Oncology, 1987 - 1990
  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Pediatrics, 1985 - 1987
  • Johns Hopkins University School of Medicine
    Johns Hopkins University School of MedicineClass of 1985

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 1987 - 2025
  • FL State Medical License
    FL State Medical License 2014 - 2016

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

Publications & Presentations

PubMed

Abstracts/Posters

  • DOCK2 Expression Affects Leukemogenesis and Disease Progression in a Murine Model of FLT3/ITD Acute Myeloid Leukemia
    Donald Small, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Dissociation of the DNMT3A-HDAC1 Repressor Complex Induces PD-L1 Expression
    Donald Small, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • FLT3 Inhibitor Correlative Laboratory Assays Impact Outcomes in KMT2A-Rearranged Infant Acute Lymphoblastic Leukemia (ALL) Patients Treated with Lestaurtinib: AALL0631...
    Donald Small, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

  • Combinatorial Approaches to Overcome Plasma Protein Inhibition of FLT3 Tyrosine Kinase Inhibitors 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • Scientists Identify 'Mutation Accelerator' in Gene Mutation Linked to Common Adult Leukemia
    Scientists Identify 'Mutation Accelerator' in Gene Mutation Linked to Common Adult LeukemiaJune 10th, 2015

Hospital Affiliations